Crescent Biopharma(DE:C68)
€11.80+0.40 (+3.51%)
DE:C68
Crescent Biopharma earnings date
€11.80
At close:+0.40 (+3.51%)
Crescent Biopharma (C68) Q4 2023 Earnings Report
2 Followers
DE:C68 Q4 2023 EPS Results
- Actual EPS
- -EUR 12.66
- Consensus EPS
- -EUR 13.78
- Beat/Miss
- Beat by +EUR 1.13
- One Year Ago EPS
- -EUR 17.17
DE:C68 Q4 2023 Revenue Results
- Actual Revenue
- EUR 9,039.295
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 9,039.295
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/27/2024
- Time
- Before Open
- Conference Call
- Wednesday, March 27, 2024
DE:C68 Upcoming Earnings
Crescent Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:C68 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C68 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.66- | -3.62 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.63-0.81 | -1.15 | 29.13% (+0.33) | |
| Jul 30, 2026 | 2026 (Q2) | -0.67-0.67 | -4.46 | 84.99% (+3.79) | |
| Apr 29, 2026 | 2026 (Q1) | -0.79-0.63 | -16.11 | 96.07% (+15.48) | |
| Feb 26, 2026 | 2025 (Q4) | -2.23-3.62 | -7.23 | 49.88% (+3.61) | |
| Nov 06, 2025 | 2025 (Q3) | -1.77-1.15 | -325.75 | 99.65% (+324.60) | |
| Jul 31, 2025 | 2025 (Q2) | -1.51-4.46 | -14.15 | 68.51% (+9.70) | |
| May 01, 2025 | 2025 (Q1) | -0.05-0.05 | -0.15 | 70.59% (+0.11) | |
| Feb 27, 2025 | 2024 (Q4) | -0.07-0.10 | -0.13 | 20.00% (+0.03) | |
| Nov 07, 2024 | 2024 (Q3) | -0.10-0.14 | -0.13 | -8.57% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
